The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 10, Pages 3071
Publisher
MDPI AG
Online
2020-10-23
DOI
10.3390/cancers12103071
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Distinguishing Specific CXCL12 Isoforms on Their Angiogenesis and Vascular Permeability Promoting Properties
- (2020) Chia‐Wen Chang et al. Advanced Healthcare Materials
- Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4
- (2020) Ying Wang et al. Frontiers in Oncology
- Organotypic breast tumor model elucidates dynamic remodeling of tumor microenvironment
- (2020) Sunil Singh et al. BIOMATERIALS
- Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs
- (2020) Maren Pein et al. Nature Communications
- Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
- (2020) Qingjian Li et al. Nature Communications
- Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis
- (2019) Ramy Gadalla et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG
- (2019) Yan Gu et al. NATURE MEDICINE
- Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
- (2019) Ivy X. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dual blockade of CXCL12-CXCR4 and PD-1–PD-L1 pathways prolongs survival of ovarian tumor–bearing mice by prevention of immunosuppression in the tumor microenvironment
- (2019) Yang Zeng et al. FASEB JOURNAL
- Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor
- (2019) Kamal Ahmed et al. CANCER LETTERS
- LRP6 ectodomain prevents SDF-1/CXCR4-induced breast cancer metastasis to lung
- (2019) Jiankang Zhang et al. CLINICAL CANCER RESEARCH
- CXCL12/CXCR4 pathway orchestrates CSC-like properties by CAF recruited tumor associated macrophage in OSCC
- (2019) Xing Li et al. EXPERIMENTAL CELL RESEARCH
- Autocrine TGF-β1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation
- (2019) Xi Tang et al. CANCER LETTERS
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences
- (2019) Florian R. Greten et al. IMMUNITY
- POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages
- (2019) Samuel Seoane et al. JOURNAL OF PATHOLOGY
- CXCR4 knockdown prevents inflammatory cytokine expression in macrophages by suppressing activation of MAPK and NF-κB signaling pathways
- (2019) Xue Tian et al. Cell and Bioscience
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Systemic treatment of patients with early breast cancer: recent updates and state of the art
- (2019) Rafael Caparica et al. BREAST
- Information Theory: New Look at Oncogenic Signaling Pathways
- (2019) K.A. Zielińska et al. TRENDS IN CELL BIOLOGY
- Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling
- (2019) Gardiyawasam Kalpana et al. Scientific Reports
- CXCL12-CXCL4 heterodimerization prevents CXCL12-driven breast cancer cell migration
- (2019) Khanh T.P. Nguyen et al. CELLULAR SIGNALLING
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- CXCR4 antagonist AMD3100 enhances the response of MDA-MB-231 triple-negative breast cancer cells to ionizing radiation
- (2018) K.X. Zhou et al. CANCER LETTERS
- Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
- (2018) Binghao Li et al. CANCER RESEARCH
- Rac1 plays a role in CXCL12 but not CCL3-induced chemotaxis and Rac1 GEF inhibitor NSC23766 has off target effects on CXCR4
- (2018) Shirley C. Mills et al. CELLULAR SIGNALLING
- Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells
- (2018) Subbroto Saha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
- (2018) Sonia Pernas et al. LANCET ONCOLOGY
- VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin
- (2018) Yuhui Wang et al. MOLECULES
- Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation
- (2018) Dinesh K. Ahirwar et al. ONCOGENE
- Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis
- (2018) Anxo Martinez-Ordoñez et al. ONCOGENE
- Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2)
- (2018) Kaitlyn M. Dvorak et al. PLoS One
- HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice
- (2018) Claire-Sophie Devignes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of CXCR4 silencing with shRNA on MAPK signaling in ovarian cancer
- (2018) Xiuli Wang et al. Oncology Letters
- miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
- (2018) Anne-Marie Givel et al. Nature Communications
- A Unidirectional Transition from Migratory to Perivascular Macrophage Is Required for Tumor Cell Intravasation
- (2018) Esther N. Arwert et al. Cell Reports
- Tumor initiating cells induce Cxcr4-mediated infiltration of pro-tumoral macrophages into the brain
- (2018) Kelda Chia et al. eLife
- Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness
- (2018) Maximilian Boesch et al. OncoImmunology
- Lidocaine inhibits cytoskeletal remodelling and human breast cancer cell migration
- (2018) G. D'Agostino et al. BRITISH JOURNAL OF ANAESTHESIA
- CXCR4-targeted therapy in breast cancer
- (2018) Thorsten Derlin et al. LANCET ONCOLOGY
- The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
- (2018) Katharina Helene Susek et al. Frontiers in Immunology
- Inhibition of dipeptidyl peptidase-4 accelerates epithelial-mesenchymal transition and breast cancer metastasis via the CXCL12/CXCR4/mTOR axis
- (2018) Fan Yang et al. CANCER RESEARCH
- Forkhead box C1 boosts triple-negative breast cancer metastasis through activating the transcription of chemokine receptor-4
- (2018) Hongchao Pan et al. CANCER SCIENCE
- Pathological roles of the homeostatic chemokine CXCL12
- (2018) Rik Janssens et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis
- (2018) Muthu K. Shanmugam et al. Frontiers in Pharmacology
- Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
- (2018) Nicolas Jacquelot et al. Frontiers in Immunology
- Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
- (2018) Franziska Eckert et al. Frontiers in Immunology
- CXCR4 targeted dendrimer for anti-cancer drug delivery and breast cancer cell migration inhibition
- (2017) Chuda Chittasupho et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis
- (2017) I. Aversa et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function
- (2017) You-Hong Cheng et al. PLoS One
- Targeting CXCR4-dependent immunosuppressive Ly6Clowmonocytes improves antiangiogenic therapy in colorectal cancer
- (2017) Keehoon Jung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Inflammation and Cytokines
- (2017) Maria Rosaria Galdiero et al. Cold Spring Harbor Perspectives in Biology
- The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism
- (2017) Qing-Ling Yang et al. Oncotarget
- Three-dimensional tumor model mimics stromal – breast cancer cells signaling
- (2017) Stephanie Lemmo Ham et al. Oncotarget
- Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate)
- (2016) Farzana Alam et al. BIOMATERIALS
- Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation
- (2016) Raffaella Bonecchi et al. CYTOKINE
- Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression
- (2016) Christopher J. Coke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via Hypoxia-Inducible Factor 1α
- (2016) Cynthia Lopez-Haber et al. MOLECULAR AND CELLULAR BIOLOGY
- CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
- (2016) S Lefort et al. ONCOGENE
- Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis
- (2016) P F Yu et al. ONCOGENE
- Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone
- (2016) Trevor T. Price et al. Science Translational Medicine
- Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression
- (2016) Daniela Rovito et al. Oncotarget
- Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis
- (2016) Debarati Mukherjee et al. Oncotarget
- Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo
- (2016) Rik Janssens et al. Oncotarget
- G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis
- (2016) Matthew J. Billard et al. PLoS One
- Inhibition of Wnt signalling and breast tumour growth by the multi-purpose drug suramin through suppression of heterotrimeric G proteins and Wnt endocytosis
- (2015) A. Koval et al. BIOCHEMICAL JOURNAL
- SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction
- (2015) Jennifer Pasquier et al. BMC CANCER
- Inhibition of SDF-1/CXCR4-induced epithelial–mesenchymal transition by kisspeptin-10
- (2015) Carsten Gründker et al. BREAST CANCER RESEARCH AND TREATMENT
- Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
- (2015) R. Hughes et al. CANCER RESEARCH
- CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
- (2015) J. Xiang et al. MOLECULAR CANCER THERAPEUTICS
- Endothelial CXCR7 regulates breast cancer metastasis
- (2015) A C Stacer et al. ONCOGENE
- Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance
- (2015) Marina Okuyama Kishima et al. Analytical Cellular Pathology
- GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells
- (2015) Shingo Inaguma et al. Oncotarget
- Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis
- (2015) Miho Riku et al. Oncotarget
- TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model
- (2015) Hendrik Fritsche et al. Oncotarget
- CXCR4 over-expression and survival in cancer: A system review and meta-analysis
- (2015) Hongli Zhao et al. Oncotarget
- Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo
- (2015) Kazem Zibara et al. Scientific Reports
- AMD3100/CXCR4 Inhibitor
- (2015) Erik De Clercq Frontiers in Immunology
- Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy
- (2015) Kentaro Nobutani et al. PLoS One
- Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype
- (2015) Katia Beider et al. Oncotarget
- ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling
- (2015) Tetsuro Masuda et al. Scientific Reports
- Stromal Cell–Derived Factor-1α/C-X-C Chemokine Receptor Type 4 Axis Promotes Endothelial Cell Barrier Integrity via Phosphoinositide 3-Kinase and Rac1 Activation
- (2014) Koji Kobayashi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
- (2014) Zhigang Zhang et al. BMC CANCER
- The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
- (2014) Ruth Scherz-Shouval et al. CELL
- The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers
- (2014) Christelle Freitas et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Chemokines in Cancer
- (2014) M. T. Chow et al. Cancer Immunology Research
- miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis
- (2013) Yun Zhang et al. NATURE CELL BIOLOGY
- A review on CXCR4/CXCL12 axis in oncology: No place to hide
- (2012) Urszula M. Domanska et al. EUROPEAN JOURNAL OF CANCER
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- CXCR4/CXCL12 Participate in Extravasation of Metastasizing Breast Cancer Cells within the Liver in a Rat Model
- (2012) Claudia Wendel et al. PLoS One
- CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
- (2011) E. Righi et al. CANCER RESEARCH
- CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
- (2011) Fabien M. Décaillot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential Estrogen-Regulation of CXCL12 Chemokine Receptors, CXCR4 and CXCR7, Contributes to the Growth Effect of Estrogens in Breast Cancer Cells
- (2011) Antoine Boudot et al. PLoS One
- A Synthetic Biology Approach Reveals a CXCR4-G13-Rho Signaling Axis Driving Transendothelial Migration of Metastatic Breast Cancer Cells
- (2011) H. Yagi et al. Science Signaling
- The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
- (2010) L. Sanchez-Martin et al. BLOOD
- CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
- (2010) S Singh et al. BRITISH JOURNAL OF CANCER
- Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer
- (2010) Lyndsay V. Rhodes et al. CANCER RESEARCH
- Multiple functions of CXCL12 in a syngeneic model of breast cancer
- (2010) Sharon A Williams et al. Molecular Cancer
- Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands
- (2010) K E Luker et al. ONCOGENE
- LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
- (2010) C.-C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
- (2010) Y. Kojima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemokines and chemokine receptors: new insights into cancer-related inflammation
- (2010) Gwendal Lazennec et al. TRENDS IN MOLECULAR MEDICINE
- Positive Feedback Activation of Estrogen Receptors by the CXCL12-CXCR4 Pathway
- (2009) K. Sauve et al. CANCER RESEARCH
- High Chemokine Receptor CXCR4 Level in Triple Negative Breast Cancer Specimens Predicts Poor Clinical Outcome
- (2008) Quyen D. Chu et al. JOURNAL OF SURGICAL RESEARCH
- Chemokine signaling in cancer: One hump or two?
- (2008) Joshua B. Rubin SEMINARS IN CANCER BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started